Home/Publication/Hostplus et al to Tackle Chronic Inflammatory Diseases
Hostplus et al to Tackle Chronic Inflammatory Diseases 

13 Nov 2025

US$ 20.00

Hostplus and IP Group Australia have co-led the A$29 m (US$19 m) series A round of RAGE Biotech Pty Ltd (Rage Biotech),...

Price / article: US$20.00
OR existing subscriber
Related Publications

International Finance Corp is planning to invest up to US$60 m to Allianz Asia Pacific Infrastructure Credit Fund ......

MPCi and GL Ventures have co-led the pre-series A funding round of Shenzhen Yifang Innovation Technology Co Ltd ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.